For decades, the United States has led the world in pharmaceutical innovation – developing drugs that combat cancer, heart ...

Novo Nordisk shares rose Monday as the company said it would present new data on the ability of semaglutide, the active ...

LONDON (Reuters) -Danish company Novo Nordisk's membership in a UK pharmaceutical industry body has been restored after a two ...

Medications like Ozempic and Mounjaro work by mimicking naturally occurring hormones in the body, such as glucagon-like ...

Novo Nordisk’s (NVO) etavopivat was granted FDA orphan designation for treatment of thalassemias, according to a post on the agency’s ...

Drug compounders are moving to block the FDA’s decision that Novo Nordisk A/S’s weight loss drug is no longer in shortage, ...

Student scientists have developed an incredible new way to synthesize drugs on plants — and they're using Ozempic as their ...

Brazilian drugmaker Hypera plans to launch next year a generic version of semaglutide, the active ingredient of Novo Nordisk's blockbuster diabetes and weight-loss drug Ozempic, Hypera's chief ...

While the number of prescription fills for GLP-1 receptor agonists has continued to increase, health Insurance coverage for ...

The FDA ordered compounding pharmacies to stop making copycat versions of weight loss drugs like Ozempic and Zepbound now ...

With official shortages ended, but the first generics gearing up for launch, companies are looking for the next generation of ...